Compare PulteGroup, Inc. (PHM) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PulteGroup, Inc. vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? PulteGroup, Inc. trades at $111.76 (market cap $21.63B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.61 (market cap $2.27B). The key difference: PulteGroup, Inc. is far larger — about 9.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and PulteGroup, Inc. pays a 0.92% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| PHM | SLS | |
|---|---|---|
Market Cap | $21.63B | $2.27B |
Volume | 2,324,729 | 4,179,659 |
Sector | Consumer Cyclical | Health |
52-Week High | $142.56 | $15.46 |
52-Week Low | $110.11 | $1.39 |
Typical Hold Time | 91 Days | — |
Enterprise Value | $22.04B | $2.14B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PulteGroup (PHM) trades at $111.76, down 0.51% amid broader housing sector pressure from rising mortgage rates. The stock shows bearish technical signals with support near $109-110, while fundamentals reveal solid profitability (11.62% net margin) but declining revenue and earnings trends. Recent quarters show mixed earnings performance with two misses and one beat against expectations.
PHM presents a value opportunity with attractive valuation multiples (P/E 11.6) and analyst consensus target of $139.80, but faces headwinds from housing affordability concerns and volatile cash flows. The stock's near-term trajectory depends on Q3 2026 earnings results due October 22, 2026, with institutional ownership remaining stable despite sector challenges.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
